Santa Cruz Biotechnology is focused on the ongoing development of research antibodies, with a goal of offering the broadest range of research reagents in the field. The company offers more than 2,850 target-specific 19-25 nucleotide siRNAs that can be used to knockdown protein expression in a broad variety of mammalian cell types. Its primary product line includes siRNAs designed to silence a large selection of proteins including tumor suppressors, kinases, transcription regulators, cell cycle proteins, membrane receptors, kinases, signaling intermediates, cell adhesion proteins and proteins involved in lymphocyte signaling. The company s secondary product line provides a new method for the detection of immunoprecipitated proteins via western blot analysis. Santa Cruz Biotechnology offers online ordering for all its products. The company is headquartered in Santa Cruz, Calif.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.